Sales rise 16.50% to Rs 35.51 crore
Net profit of Jenburkt Pharmaceuticals rose 40.56% to Rs 7.97 crore in the quarter ended September 2021 as against Rs 5.67 crore during the previous quarter ended September 2020. Sales rose 16.50% to Rs 35.51 crore in the quarter ended September 2021 as against Rs 30.48 crore during the previous quarter ended September 2020. ParticularsQuarter EndedSep. 2021Sep. 2020% Var.Sales35.5130.48 17 OPM %28.9223.52 -PBDT11.358.07 41 PBT10.907.56 44 NP7.975.67 41Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
